Breaking News

Versant-founded cancer drug startup launches with $90M

Not rendering correctly? View this email as a web page here.

Tackling the monkeypox outbreak: The applied behavioral science lessons the Biden administration should learn

By Ram Prasad and Alok Gangaramany Friday, October 7, 2022 4:00 PM

By learning from the mistakes of the past, the U.S. government and its international partners can create a more effective response to the monkeypox outbreak than they have for previous health emergencies.

Read more »

Pediatric mental health startup launches with $26M and a vow to scale Mass General's proven care model

By Katie Adams Friday, October 7, 2022 3:59 PM

InStride Health — a virtual care provider for pediatric patients with moderate to severe anxiety and OCD — recently launched with $26 million in funding. The startup delivers insurance-covered pediatric mental health treatment using a care model developed by two of its co-founders, who are Mass General Brigham clinicians.

Read more »

Star ratings for Medicare Advantage, Part D see sharp drop for 2023, CMS shows

By Marissa Plescia Friday, October 7, 2022 2:09 PM

There are 260 MA plans with Part D coverage that received four stars or more for 2023, a share of about 51%. This is a steep decline from 2022, when there were 322 plans with four stars or more, accounting for about 68% of plans.

Read more »

BioMarin layoffs to save $50M a year; cash will go to pipeline, gene therapy launch prep

By Frank Vinluan Friday, October 7, 2022 11:59 AM

BioMarin Pharmaceutical said the layoffs will improve efficiency across the company as it prepares for the potential U.S. launch of Roctavian, a gene therapy for severe hemophilia A. The one-time treatment was approved in Europe in August.

Read more »

   

No comments